Interesting piece and one of the few times I have seen anyone discuss opportunity cost in this debate.  A physician, who is not an epidemiologist but does have a background in economics, discusses the COVID vaccine distribution plans.  He makes some thought-provoking points including whether or not we should check for antibodies and place those that already have them at the back of the line.

The Current COVID-19 Vaccine Roll-Out Doesn't Make Sense

 

E-mail me when people leave their comments –

You need to be a member of UNH Economics Collective to add comments!

Join UNH Economics Collective